Stock Insights: Higher One, Veeco, Gap, GNC, Procter & Gamble May 1st

Procter & Gamble Co. (NYSE:PG): BMO Capital reduced its target on Procter & Gamble after the company reported higher than expected Q3 EPS but lowered its FY12 guidance. The firm thinks that the company’s competitors are handling headwinds more skillfully than Procter & Gamble, but it maintains an Outperform rating on the stock, citing several longer term catalysts.


Higher One Inc. (NYSE:ONE): After Higher One highlighted weaker than expected enrollment trends in a March 26 regulatory filing, Piper Jaffray believes the company will lower its 2012 guidance when reporting March quarter results after the close tonight. Piper lowered its price target for shares to $19 from $21 but maintains an Overweight rating on the name.

Veeco Instruments Inc. (NASDAQ:VECO): Citigroup believes Veeco’s orders for Q2 are down meaningfully, which it feels could create downside potential for the stock should the shares rally today on the company’s Q1 results. The firm keeps a Neutral rating on the stock with a $27 price target.

Gap Inc. (NYSE:GPS): Jefferies believes Gap’s hiring of Stefan Larsson as Global Brand President for Old Navy is a significant positive catalyst and continues to recommend buying Gap shares. The firm keeps a Buy rating on the name with a $40 price target.

GNC Holdings Inc (NYSE:GNC): After the FDA told ten DMAA manufacturers that they would have to show that their products are safe within 15 business days, and the agency indicated that the products could be pulled from shelves if the companies fail to do so, BMO Capital predicts that consumers will simply substitute other performance-enhancers for DMAA, in the unlikely event that the DMAA products are removed. The firm maintains an Outperform rating on GNC.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.